ID

30756

Description

Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations; ODM derived from: https://clinicaltrials.gov/show/NCT00792363

Lien

https://clinicaltrials.gov/show/NCT00792363

Mots-clés

Versions (1)
  1. 19/06/2018 19/06/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

19 juin 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Metastatic Colorectal Cancer NCT00792363

Anglais

Eligibility Metastatic Colorectal Cancer NCT00792363

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically verified adenocarcinoma in colon or rectum with metastatic spread.
Description

Adenocarcinoma of colon metastatic | Adenocarcinoma of rectum metastatic

Type de données

boolean

Alias
UMLS CUI [1]
C4324497
UMLS CUI [2,1]
C0149978
UMLS CUI [2,2]
C1522484
no mutations in the kras gene.
Description

KRAS Gene Mutation Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1517649
UMLS CUI [1,2]
C0332197
resistance to 5-fu, oxaliplatin and irinotecan.
Description

Fluorouracil Resistant | Oxaliplatin Resistant | Irinotecan Resistant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0016360
UMLS CUI [1,2]
C0332325
UMLS CUI [2,1]
C0069717
UMLS CUI [2,2]
C0332325
UMLS CUI [3,1]
C0123931
UMLS CUI [3,2]
C0332325
age ≥18 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ps 0-2.
Description

Performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1518965
measurable disease according to recist criteria.
Description

Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
haematology: neutrophilocytes ≥1.5 x 109/l, leukocytes ≥3.0 x 109/l, thrombocytes
Description

Hematology | Neutrophil count | White Blood Cell Count procedure | Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0200627
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0023508
UMLS CUI [4]
C0032181
≥100 and bilirubinaemia ≤3 x upper normal value. samples no more than 4 weeks old.
Description

Bilirubinemia

Type de données

boolean

Alias
UMLS CUI [1]
C0020433
fertile women must present a negative pregnancy test and use secure birth control during and 3 months after treatment.
Description

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
acceptance that blod and tissue samples are kept for subsequent investigation of biomarkers.
Description

Availability of Blood specimen | Availability of Tissue specimen | Evaluation Biological Markers

Type de données

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0178913
UMLS CUI [2,1]
C0470187
UMLS CUI [2,2]
C1292533
UMLS CUI [3,1]
C1261322
UMLS CUI [3,2]
C0005516
oral and written informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
other malignant disease within the past 5 years, excl. non-melanoma skin cancer and carcinoma in situ cervicis uteri.
Description

Cancer Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
chemotherapy, radiotherapy or immunotherapy within the past 4 weeks.
Description

Chemotherapy | Therapeutic radiology procedure | Immunotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0021083
verified or clinically suspected cns metastasis.
Description

CNS metastases | CNS metastases Suspected

Type de données

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0750491
other experimental treatment.
Description

Therapy, Investigational

Type de données

boolean

Alias
UMLS CUI [1]
C0949266
serious medical disease according to investigator's judgement.
Description

Disease Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
pregnant or breastfeeding women.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
hypersensitivity to the active substance or to one or more of the auxiliary substances.
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Adjuvants Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0001552
UMLS CUI [2,3]
C1265611
patients with interstitial pneumonitis or pulmonary fibrosis.
Description

Pneumonia, Interstitial | Pulmonary Fibrosis

Type de données

boolean

Alias
UMLS CUI [1]
C0206061
UMLS CUI [2]
C0034069
Retour au début de la page

Similar models

Eligibility Metastatic Colorectal Cancer NCT00792363

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of colon metastatic | Adenocarcinoma of rectum metastatic
Item
histologically verified adenocarcinoma in colon or rectum with metastatic spread.
boolean
C4324497 (UMLS CUI [1])
C0149978 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
KRAS Gene Mutation Absent
Item
no mutations in the kras gene.
boolean
C1517649 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Fluorouracil Resistant | Oxaliplatin Resistant | Irinotecan Resistant
Item
resistance to 5-fu, oxaliplatin and irinotecan.
boolean
C0016360 (UMLS CUI [1,1])
C0332325 (UMLS CUI [1,2])
C0069717 (UMLS CUI [2,1])
C0332325 (UMLS CUI [2,2])
C0123931 (UMLS CUI [3,1])
C0332325 (UMLS CUI [3,2])
Age
Item
age ≥18 years.
boolean
C0001779 (UMLS CUI [1])
Performance status
Item
ps 0-2.
boolean
C1518965 (UMLS CUI [1])
Measurable Disease
Item
measurable disease according to recist criteria.
boolean
C1513041 (UMLS CUI [1])
Hematology | Neutrophil count | White Blood Cell Count procedure | Platelet Count measurement
Item
haematology: neutrophilocytes ≥1.5 x 109/l, leukocytes ≥3.0 x 109/l, thrombocytes
boolean
C0200627 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0023508 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
Bilirubinemia
Item
≥100 and bilirubinaemia ≤3 x upper normal value. samples no more than 4 weeks old.
boolean
C0020433 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
fertile women must present a negative pregnancy test and use secure birth control during and 3 months after treatment.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Availability of Blood specimen | Availability of Tissue specimen | Evaluation Biological Markers
Item
acceptance that blod and tissue samples are kept for subsequent investigation of biomarkers.
boolean
C0470187 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0470187 (UMLS CUI [2,1])
C1292533 (UMLS CUI [2,2])
C1261322 (UMLS CUI [3,1])
C0005516 (UMLS CUI [3,2])
Informed Consent
Item
oral and written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cancer Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix
Item
other malignant disease within the past 5 years, excl. non-melanoma skin cancer and carcinoma in situ cervicis uteri.
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
Chemotherapy | Therapeutic radiology procedure | Immunotherapy
Item
chemotherapy, radiotherapy or immunotherapy within the past 4 weeks.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
CNS metastases | CNS metastases Suspected
Item
verified or clinically suspected cns metastasis.
boolean
C0686377 (UMLS CUI [1])
C0686377 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Therapy, Investigational
Item
other experimental treatment.
boolean
C0949266 (UMLS CUI [1])
Disease Serious
Item
serious medical disease according to investigator's judgement.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Adjuvants Quantity
Item
hypersensitivity to the active substance or to one or more of the auxiliary substances.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0001552 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Pneumonia, Interstitial | Pulmonary Fibrosis
Item
patients with interstitial pneumonitis or pulmonary fibrosis.
boolean
C0206061 (UMLS CUI [1])
C0034069 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial